Center for Evidence-Based and Translational Medicine, Zhongnan Hospital of Wuhan University, Wuhan, 430071, China.
Department of Health Research, Evidence and Impact, McMaster University, Hamilton, Ontario, L8S 4L8, Canada.
Mil Med Res. 2021 Feb 3;8(1):10. doi: 10.1186/s40779-021-00298-4.
We published rapid advice guidelines and updated guidelines for coronavirus disease 2019 (COVID-19) management on February 6, 2020, and September 4, 2020, respectively. These two guidelines vary widely in their developmental background, type of evidence, grade of recommendation and so on. We shared our experience for the development of these two guidelines to help clinical practitioners better understand and implement guidelines and to help guideline developers facilitate communication and discussion for guideline development during the pandemic.
我们分别于 2020 年 2 月 6 日和 9 月 4 日发布了针对 2019 冠状病毒病（COVID-19）管理的快速建议指南和更新指南。这两个指南在其发展背景、证据类型、推荐等级等方面有很大的不同。我们分享了这两个指南的制定经验，以帮助临床医生更好地理解和实施指南，并帮助指南制定者在大流行期间促进指南制定的沟通和讨论。
